BOLT — Bolt Biotherapeutics
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 24 SEC-registered investment managers reported holding BOLT (Bolt Biotherapeutics) in their latest 13F filings, with a combined reported value of $2.38M across 615.65K shares. That is +6.3% by share count (+34.97K shares) versus the previous quarter, while reported value moved +1.4%. Ownership is concentrated: the five largest holders account for 65.2% of reported value and the top ten for 89.1%.
Compared with the prior quarter, 3 opened new positions, 5 added to existing stakes, 4 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of Bolt Biotherapeutics (BOLT) include ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., Acuitas Investments, LLC, ranked by reported 13F value among the 70 institutional holders on this page.
BOLT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 16 | 319.72K | $1.17M | +1.4% |
| Q2 2026 | 24 | 615.65K | $2.38M | +6.3% |
| Q1 2026 | 24 | 613.25K | $2.49M | -7.0% |
| Q4 2025 | 21 | 602.54K | $3.30M | -15.6% |
| Q3 2025 | 23 | 791.71K | $4.21M | -13.4% |
| Q2 2025 | 25 | 887.53K | $5.10M | -95.1% |
| Q1 2025 | 29 | 18.33M | $7.33M | +0.5% |
| Q4 2024 | 39 | 18.70M | $10.02M | +0.1% |
Over the 8 quarters shown, institutional share counts decreased 98% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (-95.1%).
Top Institutional Holders (Q3 2026) — 16 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 92.92K | $341.96K | 0.00% | Reduce | |
| 72.41K | $266.48K | 0.03% | Hold | |
| 38.00K | $139.84K | 0.26% | Hold | |
| 31.30K | $112.07K | 0.07% | Hold | |
| 27.50K | $101.20K | 0.07% | Hold | |
| 15.80K | $58.15K | 0.00% | Reduce | |
| 15.53K | $57.16K | 0.00% | Add | |
| 9.71K | $35.74K | 0.00% | Hold | |
| 7.06K | $25.98K | 0.00% | Hold | |
| 5.00K | $18.40K | 0.01% | Hold | |
| 4.17K | $15.34K | 0.00% | Add | |
| 290 | $1.06K | 0.00% | Add | |
| 10 | $37 | 0.00% | Reduce | |
| 6 | $22 | 0.00% | Hold | |
| 2 | $7 | 0.00% | Reduce | |
| 1 | $4 | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 24 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 137.72K | $530.23K | 0.03% | Hold | |
| 98.62K | $379.71K | 0.00% | Add | |
| 72.41K | $278.79K | 0.03% | Hold | |
| 56.90K | $219.08K | 0.00% | Add | |
| 38.00K | $146.30K | 0.22% | Hold | |
| 35.98K | $138.51K | 0.03% | Hold | |
| 31.30K | $133.83K | 0.08% | Hold | |
| 30.80K | $118.58K | 0.01% | Hold | |
| 27.50K | $105.88K | 0.08% | Hold | |
| 19.12K | $73.62K | 0.00% | New | |
| 19.12K | $73.62K | 0.00% | Reduce | |
| 15.44K | $59.44K | 0.01% | Add | |
| 9.71K | $37.39K | 0.00% | Hold | |
| 7.06K | $27.18K | 0.00% | Hold | |
| 5.00K | $19.25K | 0.01% | Reduce | |
| 3.15K | $12.11K | 0.00% | Reduce | |
| 3.10K | $11.92K | 0.00% | Hold | |
| 2.53K | $9.74K | 0.00% | New | |
| 1.71K | $6.58K | 0.00% | Add | |
| 255 | $982 | 0.00% | Reduce | |
| 130 | $501 | 0.00% | Add | |
| 42 | $165 | 0.00% | Hold | |
| 41 | $158 | 0.00% | New | |
| 6 | $23 | 0.00% | Hold |
Q1 2026 — 24 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 137.72K | $556.39K | 0.02% | Hold | |
| 77.22K | $311.99K | 0.00% | Add | |
| 72.41K | $292.55K | 0.02% | Hold | |
| 42.58K | $172.03K | 0.06% | Reduce | |
| 38.00K | $153.52K | 0.26% | Hold | |
| 35.98K | $145.35K | 0.02% | Hold | |
| 31.30K | $137.12K | 0.06% | Hold | |
| 30.80K | $124.43K | 0.02% | New | |
| 29.25K | $118.17K | 0.10% | Reduce | |
| 28.79K | $116.33K | 0.00% | Add | |
| 27.50K | $111.10K | 0.10% | Add | |
| 14.90K | $60.22K | 0.01% | Reduce | |
| 11.66K | $47.09K | 0.00% | New | |
| 10.11K | $40.84K | 0.00% | New | |
| 9.71K | $39.23K | 0.00% | Hold | |
| 7.06K | $28.52K | 0.00% | New | |
| 3.19K | $12.88K | 0.00% | Add | |
| 3.10K | $12.50K | 0.00% | New | |
| 1.09K | $4.42K | 0.00% | Add | |
| 787 | $3.18K | 0.00% | Add | |
| 42 | $179 | 0.00% | Hold | |
| 24 | $97 | 0.00% | New | |
| 10 | $40 | 0.00% | Hold | |
| 6 | $24 | 0.00% | Hold |
Q4 2025 — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 137.72K | $753.06K | 0.03% | Hold | |
| 94.57K | $517.12K | 0.20% | Hold | |
| 72.41K | $395.96K | 0.03% | Reduce | |
| 58.35K | $319.04K | 0.29% | Hold | |
| 55.02K | $300.88K | 0.00% | Add | |
| 38.00K | $207.78K | 0.34% | New | |
| 35.98K | $196.72K | 0.04% | Hold | |
| 31.30K | $171.18K | 0.07% | Hold | |
| 20.50K | $112.09K | 0.10% | New | |
| 18.80K | $103.06K | 0.00% | Add | |
| 15.27K | $83.51K | 0.01% | Reduce | |
| 10.18K | $55.78K | 0.00% | Reduce | |
| 9.71K | $53.10K | 0.00% | Hold | |
| 3.13K | $17.10K | 0.00% | Hold | |
| 723 | $3.95K | 0.00% | Add | |
| 515 | $2.82K | 0.00% | Add | |
| 256 | $1.40K | 0.00% | New | |
| 42 | $230 | 0.00% | Hold | |
| 31 | $169 | 0.00% | Hold | |
| 10 | $55 | 0.00% | Hold | |
| 6 | $33 | 0.00% | Hold |
Q3 2025 — 23 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 176.06K | $936.66K | 0.07% | Hold | |
| 137.72K | $732.68K | 0.04% | Hold | |
| 94.57K | $503.13K | 0.29% | Hold | |
| 66.88K | $355.80K | 0.01% | Reduce | |
| 58.35K | $310.41K | 0.52% | Hold | |
| 48.83K | $259.78K | 0.03% | Reduce | |
| 35.98K | $191.40K | 0.02% | Hold | |
| 34.23K | $182.11K | 0.00% | Reduce | |
| 31.30K | $166.54K | 0.04% | Hold | |
| 28.62K | $152.28K | 0.00% | Add | |
| 18.53K | $98.61K | 0.00% | Hold | |
| 16.64K | $88.53K | 0.00% | New | |
| 15.96K | $84.90K | 0.01% | New | |
| 14.84K | $78.93K | 0.00% | Add | |
| 9.71K | $51.66K | 0.00% | Reduce | |
| 3.13K | $16.64K | 0.00% | Reduce | |
| 259 | $1.38K | 0.00% | Reduce | |
| 42 | $223 | 0.00% | Reduce | |
| 31 | $165 | 0.00% | Reduce | |
| 10 | $53 | 0.00% | Hold | |
| 6 | $32 | 0.00% | Hold | |
| 3 | $16 | 0.00% | Reduce | |
| 2 | $11 | 0.00% | Hold |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 176.06K | $985.96K | 0.10% | Reduce | |
| 166.88K | $962.89K | 0.05% | Reduce | |
| 137.72K | $794.65K | 0.05% | Reduce | |
| 94.57K | $545.69K | 0.34% | Reduce | |
| 58.48K | $340.96K | 0.00% | Reduce | |
| 58.35K | $336.66K | 0.53% | Reduce | |
| 52.46K | $302.67K | 0.06% | Reduce | |
| 35.98K | $207.59K | 0.02% | Reduce | |
| 31.30K | $180.63K | 0.03% | Reduce | |
| 18.53K | $108.06K | 0.00% | Reduce | |
| 18.32K | $105.73K | 0.00% | Reduce | |
| 12.39K | $72.22K | 0.00% | Reduce | |
| 10.82K | $62.45K | 0.01% | Reduce | |
| 10.55K | $60.87K | 0.00% | Reduce | |
| 3.58K | $20.65K | 0.00% | Reduce | |
| 483 | $2.79K | 0.00% | New | |
| 395 | $2.28K | 0.00% | Reduce | |
| 282 | $1.63K | 0.00% | Reduce | |
| 183 | $1.06K | 0.00% | Reduce | |
| 121 | $705 | 0.00% | Reduce | |
| 43 | $251 | 0.00% | Reduce | |
| 10 | $58 | 0.00% | Reduce | |
| 6 | $35 | 0.00% | Reduce | |
| 2 | $12 | 0.00% | Reduce | |
| 1 | $6 | 0.00% | New |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 19.12K sh · $73.62K
- NewEdge Advisors, LLC 2.53K sh · $9.74K
- Citigroup Inc 41 sh · $158
Fully Exited (vs previous quarter)
- Pivotal bioVenture Partners Investment Advisor LLC sold 42.58K sh · $172.03K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP sold 11.66K sh · $47.09K
- Vanguard Global Advisers, LLC sold 24 sh · $97
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies | 92.92K | 98.62K | 77.22K | 55.02K | 28.62K | 18.32K | 314.14K | 302.04K | 294.04K | 276.74K | 517.64K | 445.27K | 314.19K | 483.94K | 456.74K | 441.54K | 393.86K | 538.57K | 290.10K | 88.90K |
| Vivo Capital, LLC | 72.41K | 72.41K | 72.41K | 72.41K | 176.06K | 176.06K | 3.52M | 3.52M | 3.52M | 3.52M | 3.52M | 3.52M | 3.87M | — | — | — | — | — | — | — |
| T3 Companies, LLC | 38.00K | 38.00K | 38.00K | 38.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PFIZER INC | 31.30K | 31.30K | 31.30K | 31.30K | 31.30K | 31.30K | 626.11K | 626.11K | — | — | — | — | — | — | — | — | — | — | — | — |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 27.50K | 27.50K | 27.50K | 20.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 15.80K | 19.12K | 28.79K | 18.80K | 18.53K | 18.53K | 375.11K | 340.67K | 352.43K | 370.79K | 347.57K | 350.16K | 360.74K | 352.22K | 177.99K | 154.08K | 142.22K | 142.22K | 326.69K | 392.13K |
| VANGUARD FIDUCIARY TRUST CO | 15.53K | 3.10K | 3.10K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 9.71K | 9.71K | 9.71K | 9.71K | 9.71K | 10.55K | 268.64K | 270.09K | 269.61K | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.06K | 7.06K | 7.06K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nan Fung Group Holdings Ltd | 5.00K | 5.00K | 29.25K | 58.35K | 58.35K | 58.35K | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | 1.17M | — | — | — | — | — | — | — |
| Morgan Stanley | 4.17K | 3.15K | 3.19K | 3.13K | 3.13K | 3.58K | 11.62K | 11.62K | 23.45K | 33.69K | 24.69K | 79.39K | 159.77K | 33.57K | 306.40K | 34.88K | 71.04K | 410.87K | 423.79K | 451.11K |
| JPMorgan Chase & Co | 290 | 42 | 42 | 42 | 42 | 43 | 906 | 911 | 914 | 840 | 840 | 840 | 76.29K | 128.65K | 189.31K | 19.91K | 2.36K | 1.45K | 65.65K | 64.86K |
| SBI Securities Co., Ltd. | 10 | 130 | 10 | 10 | 10 | 10 | 200 | 200 | — | — | — | — | — | — | — | — | — | — | — | — |
| BARCLAYS PLC | 6 | 6 | 6 | 6 | 6 | 6 | 139 | 139 | 139 | 139 | 139 | 139 | 139 | — | — | — | — | — | — | — |
| UBS Group AG | 2 | 255 | 787 | 515 | 3 | 183 | 111.51K | 66.11K | 35.30K | 48.83K | 12.17K | 7.65K | 86 | — | — | — | — | 2.51K | 1.59K | 15 |
| Citigroup Inc | 1 | 41 | — | 256 | — | — | — | — | — | — | — | 2.31K | — | — | — | 43 | 493 | 858 | 8.23K | 7.24K |
| TANG CAPITAL MANAGEMENT LLC | — | — | — | — | 66.88K | 166.88K | 3.81M | 3.81M | 3.81M | 3.81M | 3.42M | 3.65M | 3.56M | — | — | — | — | — | — | — |
| Sofinnova Investments, Inc. | — | 137.72K | 137.72K | 137.72K | 137.72K | 137.72K | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | 2.75M | — | — | — | — | — | — | — |
| Citadel Advisors | — | 56.90K | 10.11K | — | — | — | — | 78.96K | — | 2.37M | 2.42M | 2.46M | 2.85M | 2.99M | 2.84M | 2.75M | 2.75M | 2.76M | 2.75M | 2.81M |
| Pivotal bioVenture Partners Investment Advisor LLC | — | — | 42.58K | 94.57K | 94.57K | 94.57K | 1.89M | 1.89M | 1.89M | 1.89M | 1.89M | 1.89M | 1.89M | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold BOLT?
As of 2026-Q2, 24 institutional funds reported holding BOLT (Bolt Biotherapeutics) in SEC 13F filings, with a combined reported value of $2.38M.
How many shares of BOLT do institutions own?
13F filers reported 615.65K shares of BOLT, worth $2.38M in aggregate at the end of 2026-Q2.
Is institutional ownership of BOLT rising or falling?
Share counts moved +6.3% versus the prior quarter — accumulation.
Who are the top institutional holders of BOLT?
The largest 13F holders are ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., Acuitas Investments, LLC, TANG CAPITAL MANAGEMENT LLC, Renaissance Technologies; the top 25 are ranked at the top of this page.
Who are the major shareholders of Bolt Biotherapeutics?
The major shareholders of Bolt Biotherapeutics (BOLT) by reported 13F value are ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., Acuitas Investments, LLC, TANG CAPITAL MANAGEMENT LLC, Renaissance Technologies, among 70 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.